Timothy Tyson, Director at Syros Pharmaceuticals, Inc. (SYRS), bought 16,932 shares at $6.37 ($106K) on 2022-09-30, disclosed to the SEC on 2022-10-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.72 | 2,932 | $17K | 15.8% |
| 2 | $6.37 | 14,000 | $89K | 84.2% |
| Total | $6.26 avg | 16,932 | $106K | 100% |
| Ticker | Type | Filed | Value | 7d Stock | Filing |
|---|---|---|---|---|---|
| PrivateIcagen, Inc. | BUY | 2018-01-02 | $8K | — | Filing → |
| VRX | SELL |
| 2007-06-06 |
| $5K |
| — |
| Filing → |